rs1137101, LEPR

N. diseases: 77
Source: ALL
Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Obesity
CUI: C0028754
Disease: Obesity
0.100 GeneticVariation BEFREE These findings support the hypothesis that the Q223R polymorphism (but not the K109R or K656N polymorphism) of the leptin receptor gene is associated with obesity and predicts a small percentage of body weight and body composition variability in a genetically homogeneous population. 11549688 2001
Obesity
CUI: C0028754
Disease: Obesity
0.100 GeneticVariation BEFREE Obesity-related genetic factors including common polymorphisms in the leptin gene (LEP A19G and G-2548A) and its receptor (LEPR Q223R) were investigated in DNA available for 376 patients and 805 controls. 15159310 2004
Obesity
CUI: C0028754
Disease: Obesity
0.100 GeneticVariation BEFREE Because radiation at a young age may affect the hypothalamus causing leptin receptor insensitivity, we hypothesized that a polymorphism in the leptin receptor (LEPR) gene, Gln223Arg, might influence susceptibility to obesity in survivors of childhood ALL. 15337805 2004
Obesity
CUI: C0028754
Disease: Obesity
0.100 GeneticVariation BEFREE To conclude, our results support the hypothesis that Gln223Arg</span> polymorphism of LEPR in Mexican adolescents is associated with haemodynamic and metabolic disturbances related to obesity. 15660115 2005
Obesity
CUI: C0028754
Disease: Obesity
0.100 GeneticVariation BEFREE Some polymorphic genes involved in the regulation of leptin-the leptin gene (LEP A19G), the leptin receptor gene (LEPR Q223R, K109R, and K656N), and the peroxisome proliferator-activated receptor-gamma gene (PPARG P12A and C161T)--have been investigated as possible factors associated with obesity. 15972940 2005
Obesity
CUI: C0028754
Disease: Obesity
0.100 GeneticVariation BEFREE We examined the genetic associations of the G-2548A polymorphism in the promoter of the leptin (LEP) gene and the Gln223Arg (Q223R) polymorphism of the leptin receptor (LEPR) gene with obesity. 16571841 2006
Obesity
CUI: C0028754
Disease: Obesity
0.100 GeneticVariation BEFREE There was a significant difference in LEPR p.Q223</span>R polymorphism frequency when comparing obese and lean subjects, with an odds ratio of 1.92 and a 95% confidence interval of 1.15-3.22 (P = 0.013). 16788891 2006
Obesity
CUI: C0028754
Disease: Obesity
0.100 GeneticVariation BEFREE The inverse association between the Q223R polymorphism and obesity</span> (OR = 0.62; 95% CI: 0.39-0.99) remained significant even after additional adjustment for education, tobacco smoking, alcohol, physical activity, origin of the obese patient, and the -2548G > A polymorphism in the LEP gene (OR = 0.54; 95% CI: 0.32-0.89). 17031518 2006
Obesity
CUI: C0028754
Disease: Obesity
0.100 GeneticVariation BEFREE The aim of this study was to determine the incidence of the following polymorphisms in the following genes in 262 obese (BMI > or = 30) and 138 control (BMI < or = 25) subjects: leptin receptor (LEPR)-Gln223Arg, B3-adrenergic receptor (B3-AR)-Trp64Arg, serotonin transporter (5-HTT)--a 44-base pair insertion/deletion functional polymorphism in the 5-HTTLPR and insulin receptor substrate-1 (IRS-1)-Gly972Arg. 17124363 2007
Obesity
CUI: C0028754
Disease: Obesity
0.100 GeneticVariation BEFREE The haplotype combination of LEP c.-2548G>A and LEPR p.Q223R</span> variants was related to a 58% increase in obesity risk. 18273796 2007
Obesity
CUI: C0028754
Disease: Obesity
0.100 GeneticVariation BEFREE Overweight-obese subjects had significantly higher frequencies of the Arg223 allele and the Arg223 homozygous allele of Gln223Arg and the Asn656 allele of Lys656Asn compared to lean subjects. 18716356 2008
Obesity
CUI: C0028754
Disease: Obesity
0.100 GeneticVariation BEFREE Taken together, the results of our study show that the LEPR Q223R polymorphism may be associated with obesity in women with a psychotic disorder treated with atypical antipsychotic drugs and stress the importance of stratification for gender when investigating the role of variations of the LEP- and LEPR genes on the metabolic side effects of antipsychotic medications. 19142102 2009
Obesity
CUI: C0028754
Disease: Obesity
0.100 GeneticVariation BEFREE These results indicate that LEP G-2548A and LEPR Q223R SNPs may not be considered as genetic risk factors for obesity in a sample of Romanian population. 19913498 2010
Obesity
CUI: C0028754
Disease: Obesity
0.100 GeneticVariation BEFREE In children with obesity we did not observe association of the LEPR Gln223Arg gene polymorphism with obesity, leptin, insulin resistance, and metabolic abnormalities. 20156757 2009
Obesity
CUI: C0028754
Disease: Obesity
0.100 GeneticVariation BEFREE The 223Q allele was widely found among the AN-speaking study subjects, thus suggesting that the LEPR Q223R polymorphism is one of the factors contributing to the high prevalence of obesity in the Pacific Island populations. 20183928 2010
Obesity
CUI: C0028754
Disease: Obesity
0.100 GeneticVariation BEFREE The LEPR Q223R polymorphism may be a risk factor for obesity in women with a psychotic disorder treated with atypical antipsychotic drugs. 21510767 2011
Obesity
CUI: C0028754
Disease: Obesity
0.100 GeneticVariation BEFREE This study showed that LEP G2548A and LEPR Q223R polymorphisms and haplotype combination were associated with MetS and obesity risk in Tunisian volunteers. 22734460 2012
Obesity
CUI: C0028754
Disease: Obesity
0.100 GeneticVariation BEFREE Our results suggest that the LEPR gene Q223R polymorphism has an association with waist and hip circumferences in obese group but no direct association with obesity although there is a significant influence on lipid profile both in obese and non-obese subjects. 23954230 2013
Obesity
CUI: C0028754
Disease: Obesity
0.100 GeneticVariation BEFREE Our findings indicate that the LEP G2548A polymorphism is not a relevant obesity marker and that the LEPR 668A/G polymorphism may be related to obesity in a Turkish population. 24319309 2013
Obesity
CUI: C0028754
Disease: Obesity
0.100 GeneticVariation BEFREE This study was to investigate the prevalence of single nucleotide polymorphisms (SNPs) in leptin gene LEP (A19G and G2548A) and leptin receptor gene LEPR (K109R and Q223R) and their association with fasting plasma leptin level (PLL) and obesity in a Malaysian suburban population in Kampar, Perak. 24947733 2014
Obesity
CUI: C0028754
Disease: Obesity
0.100 GeneticVariation BEFREE The polymorphisms in leptin (LEP G-2548A) and leptin-receptor (LEPR Gln223Arg) seem to influence obesity and lipid metabolism among others. 26064921 2015
Obesity
CUI: C0028754
Disease: Obesity
0.100 GeneticVariation BEFREE Therefore, the present study aimed to evaluate the relationships among the gene polymorphisms ghrelin (GHRL-rs26802), ghrelin receptor (GHSR-rs572169), leptin (LEP-rs7799039), leptin receptor (LEPR-rs1137101) and fat mass and obesity-associated (FTO-rs9939609) and obesity. 26255942 2015
Obesity
CUI: C0028754
Disease: Obesity
0.100 GeneticVariation BEFREE Similarly, LEPR 668 A/G + G/G carriers with a high fat total intake had 3.0 times higher risk of obesity (p = 0.002) and 4.1 times higher risk of hypercholesterolemia (p = 0.001). 26365669 2015
Obesity
CUI: C0028754
Disease: Obesity
0.100 GeneticVariation BEFREE The aim of this study was to assess the impact of mothers' and newborns' fat mass and obesity-associated gene (FTO) rs9939609 and leptin receptor (LEPR) rs1137101 gene polymorphisms on neonatal anthropometric parameters in order to identify a potential risk for developing obesity.We performed a cross-sectional study on 355 mother-newborn couples in an Obstetrics Gynecology Tertiary Hospital from Romania, evaluated with regard to anthropometric parameters, clinical and laboratory parameters besides 2 genetic polymorphisms (FTO rs9939609 and LEPR rs1137101).Newborns with mothers carrying variant AT or AA genotype for FTO rs9939609 presented lower BMI (P = 0.012) and lower MUAC (P = 0.029). 27930556 2016
Obesity
CUI: C0028754
Disease: Obesity
0.100 GeneticVariation BEFREE The aim of this study was to investigate the association between overweight/obesity and polymorphisms in the LEP (rs7799039), LEP receptor (LEPR; rs1137101), and ADIPOQ genes (rs2241766, rs1501299) with the response to breast cancer treatment in Mexican women. 28416193 2017